These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14687994)

  • 1. Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.
    Di Nicola M; Napoli S; Anichini A; Mortarini R; Romagnoli L; Magni M; Matteucci P; Baldassarri P; Bersani I; Carlo-Stella C; Gianni AM
    Haematologica; 2003 Dec; 88(12):1396-404. PubMed ID: 14687994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
    Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
    Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
    Pietra G; Mortarini R; Parmiani G; Anichini A
    Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
    Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
    Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
    Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
    J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
    Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
    Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet B radiation sensitizes a murine epidermal dendritic cell line (XS52) to undergo apoptosis upon antigen presentation to T cells.
    Kitajima T; Ariizumi K; Bergstresser PR; Takashima A
    J Immunol; 1996 Oct; 157(8):3312-6. PubMed ID: 8871626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
    Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
    J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
    Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A
    Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates.
    Inzkirweli N; Gückel B; Sohn C; Wallwiener D; Bastert G; Lindner M
    Anticancer Res; 2007; 27(4B):2121-9. PubMed ID: 17695495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.
    Chan T; Chen Z; Hao S; Xu S; Yuan J; Saxena A; Qureshi M; Zheng C; Xiang J
    Cancer Gene Ther; 2007 Apr; 14(4):409-20. PubMed ID: 17235354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets.
    Dalgaard J; Beckstrøm KJ; Jahnsen FL; Brinchmann JE
    J Leukoc Biol; 2005 May; 77(5):689-98. PubMed ID: 15728242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia.
    Jarnjak-Jankovic S; Pettersen RD; Saebøe-Larssen S; Wesenberg F; Gaudernack G
    BMC Cancer; 2005 Feb; 5():20. PubMed ID: 15720715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
    Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
    Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
    J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage.
    Yu Q; Jones B; Hu N; Chang H; Ahmad S; Liu J; Parrington M; Ostrowski M
    Vaccine; 2006 Sep; 24(40-41):6376-91. PubMed ID: 16859816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.